MACRA

MACRA

The Medicare Access and CHIP Reauthorization Act of 2015 reformed physician payment and established new incentive frameworks for clinical performance under the Medicare program while extending the Children's Health Insurance Program authorization. Drafted and passed by the 114th United States Congress and signed by Barack Obama, it replaced the Sustainable Growth Rate mechanism and created a statutory pathway toward value-based payment, impacting a wide array of stakeholders including private payers, professional societies, and health systems. The law interacts with federal agencies such as the Centers for Medicare & Medicaid Services and has been shaped by advocacy from organizations like the American Medical Association, American Hospital Association, and specialty societies.

Background and enactment

MACRA arose from a long-standing policy debate after repeated temporary fixes to the Sustainable Growth Rate (SGR), a physician payment formula established under the Omnibus Budget Reconciliation Act of 1990 and later amended through legislation like the Balanced Budget Act of 1997. High-profile episodes in Capitol Hill deliberations involved lawmakers from committees such as the House Energy and Commerce Committee and the Senate Finance Committee, and were influenced by testimony from leaders of the American Medical Association, Federation of State Medical Boards, and patient advocacy groups including AARP and Families USA. The bipartisan compromise that produced MACRA was negotiated amid competing proposals from legislative actors like Representative Paul Ryan and Senator Pat Roberts, and incorporated provisions supported by stakeholders such as the Joint Commission and the Brookings Institution. Final passage in the House of Representatives and the Senate (United States) followed floor debates addressing budget scoring by the Congressional Budget Office and input from the Office of Management and Budget.

Key provisions and components

MACRA eliminated the SGR and instituted two major payment paths for Medicare Part B clinicians: the Merit-based Incentive Payment System and Advanced Alternative Payment Models. The Merit-based Incentive Payment System (MIPS) consolidated legacy programs including the Physician Quality Reporting System, the Value-Based Payment Modifier, and the Electronic Health Record Incentive Program into a single performance-based adjustment mechanism tied to quality, cost, advancing care information, and improvement activities. Advanced Alternative Payment Models (APMs) provided qualifying clinicians with incentive payments for participating in population-based or episode-based arrangements, building on models developed by the Center for Medicare and Medicaid Innovation, including the Bundled Payments for Care Improvement initiative and the Medicare Shared Savings Program. MACRA also included a five-year reauthorization of the Children's Health Insurance Program, along with graduate medical education provisions affecting teaching hospitals such as Johns Hopkins Hospital and Mayo Clinic.

Implementation and timeline

Implementation responsibilities fell primarily to the Centers for Medicare & Medicaid Services, which issued rulemaking under the Administrative Procedure Act and engaged stakeholders through rule proposals and comment periods. The first performance year for MIPS began in 2017, with payment adjustments phased in over subsequent years and budget-neutral scoring calibrated by the Congressional Budget Office and the Office of the Actuary (Centers for Medicare & Medicaid Services). APM qualification pathways required entities to meet thresholds for Medicare patient revenue or patient counts, triggering track transitions similar to models pursued by organizations such as Kaiser Permanente, Geisinger Health System, and Cleveland Clinic. Subsequent regulatory guidance updated performance categories, scoring weights, and low-volume thresholds, and multiple rule cycles addressed interoperability requirements influenced by the Health Information Technology for Economic and Clinical Health Act and standards bodies like Health Level Seven International.

Impact on healthcare providers and Medicare

Clinicians and institutions experienced shifts in revenue administration, reporting burden, and practice transformation incentives. Large integrated delivery networks including Partners HealthCare System and regional physician groups restructured care coordination, data analytics, and health IT investments to meet MIPS and APM requirements; solo and small practices faced concerns about administrative costs and scalability. By incentivizing outcome measurement and cost containment, the law aimed to slow Medicare spending growth and improve quality metrics that interest payers such as Blue Cross Blue Shield Association and federal programs like Medicaid. Academic medical centers and specialty societies (for example, the American College of Physicians and the American Academy of Family Physicians) developed toolkits and training programs to assist members with reporting and participation. Empirical evaluations have examined effects on spending trends, readmission rates, and preventive care delivery across systems including Veterans Health Administration partnerships.

Criticisms and controversies

MACRA generated debate over complexity, administrative burden, and equity. Critics including the American Medical Association initially raised concerns about the readiness of small practices, the adequacy of risk adjustment endorsed by researchers at institutions like Harvard Medical School and Johns Hopkins University School of Medicine, and potential unintended consequences for specialty care. Policy analysts from think tanks such as the Kaiser Family Foundation and the Urban Institute questioned the efficacy of penalty-focused incentives and the sufficiency of technical support for safety-net providers serving populations covered by Medicaid and State Children's Health Insurance Program expansions. Legal scholars and hospital associations debated the rulemaking process and the measurement constructs used by the Centers for Medicare & Medicaid Services. Ongoing controversies include the pace of transition to APMs, the distributional effects of payment adjustments, and interoperability challenges highlighted by technology vendors and standards advocates including Epic Systems Corporation and Cerner Corporation.

Category:United States federal health legislation